ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

Susan Horwitz Succeeds Waun Ki Hong As AACR President

April 12, 2002

South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study.

February 11, 2000

Report Tells NCI to Increase Funding for SPOREs.

June 30, 2006

Community Oncology Program Proves Technology Transfer Can Work; Survival Improvement Shown

March 21, 1980